Can angiotensin II type 2 receptors have deleterious effects in cardiovascular disease? Implications for therapeutic blockade of the renin-angiotensin system.
Lévy
Bernard I
BI
Institut National de la Santé et de la Recherche Médicale U 541, Hôpital Lariboisière, IFR Circulation-Lariboisière, Université Paris 7-Denis Diderot, Paris, France. levy@infobiogen.fr
D057912:Angiotensin II Type 2 Receptor Blockers; D000818:Animals; D001808:Blood Vessels / Q000502:physiology; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D002319:Cardiovascular System / Q000254:growth & development; D006801:Humans; D044140:Receptor, Angiotensin, Type 1 / Q000502:physiology; D044139:Receptor, Angiotensin, Type 2 / Q000502:physiology*; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology
D057912:Angiotensin II Type 2 Receptor Blockers; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2